US20140220624A1 - System and method for retrieval treatment of proteins in formalin-fixed paraffin-embedded tissue section - Google Patents
System and method for retrieval treatment of proteins in formalin-fixed paraffin-embedded tissue section Download PDFInfo
- Publication number
- US20140220624A1 US20140220624A1 US14/119,639 US201214119639A US2014220624A1 US 20140220624 A1 US20140220624 A1 US 20140220624A1 US 201214119639 A US201214119639 A US 201214119639A US 2014220624 A1 US2014220624 A1 US 2014220624A1
- Authority
- US
- United States
- Prior art keywords
- retrieval
- tissue section
- dispensing
- retrieval treatment
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 145
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 41
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims description 37
- 238000010438 heat treatment Methods 0.000 claims abstract description 25
- 238000005259 measurement Methods 0.000 claims abstract description 25
- 239000012188 paraffin wax Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical class O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000004949 mass spectrometry Methods 0.000 claims description 21
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 14
- 230000003213 activating effect Effects 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 description 65
- 239000000126 substance Substances 0.000 description 20
- 210000005084 renal tissue Anatomy 0.000 description 18
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 15
- 230000002255 enzymatic effect Effects 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000004451 qualitative analysis Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108010026552 Proteome Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000001871 ion mobility spectroscopy Methods 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- 206010052747 Adenocarcinoma pancreas Diseases 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 101150112743 HSPA5 gene Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 1
- 201000002094 pancreatic adenocarcinoma Diseases 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 238000000575 proteomic method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
Definitions
- the present invention relates to a system and method for a retrieval treatment of proteins contained in a formalin-fixed paraffin-embedded tissue section obtained by a formalin-fixing treatment followed by a paraffin-embedding treatment (such a tissue section is hereinafter called the “paraffin-embedded tissue section”), and more specifically, to a retrieval treatment system and method for pretreating the aforementioned tissue section in advance of a mass spectrometry.
- the bio-imaging technique for imaging a distribution of biological substances (such as proteins or metabolites) in a section of biological tissue has been used in the fields of clinical diagnoses or drug discoveries.
- this technique is widely used for an investigation of a distribution of biological substances, in which a section sample prepared by an appropriate pretreatment of a paraffin-embedded tissue section is scanned by a MALDI (matrix-assisted laser desorption ionization) mass spectrometer, and the thereby measured masses of biological substances in the section sample are comprehensively analyzed to determine the distribution of the biological substances.
- MALDI matrix-assisted laser desorption ionization
- a pretreating method described in Non-Patent Documents 1, 2, 3 and 4 has conventionally been used to make a paraffin-embedded tissue section available as a section sample for a mass spectrometry.
- This conventional pretreatment method is hereinafter described by means of the flowchart shown in FIG. 2 .
- paraffin is removed from the paraffin-embedded tissue section, after which a hydration treatment is performed to obtain a deparaffinized tissue section (S 1 ).
- a hydration treatment is performed to obtain a deparaffinized tissue section (S 1 ).
- bonding of single amino acid residues or a formation of methylene crosslink by a hydroxyl group, in particular, a strong methylene crosslink via a primary amino or phenyl radical have occurred.
- crosslinks both are referred to as “crosslinks” hereinafter
- the tissue section is subjected to a heat treatment in a retrieval treatment solution (S 2 : this treatment is hereinafter called the “retrieval treatment”).
- the retrieval treatment solution which has adhered to the deparaffinized tissue section during the retrieval treatment is washed off (S 3 ).
- the deparaffinized tissue section is treated with a digestive enzyme, such as trypsin, to hydrolyze proteins contained in the tissue section into peptides (S 4 ).
- a matrix solution is dropped onto the deparaffinized tissue section to deposit the matrix on it (S 5 ).
- the section sample thus prepared is subjected to the MALDI mass spectrometry.
- the retrieval treatment in the previously described conventional pretreatment method is not only indispensable for restoring two-dimensional and three-dimensional structures of the protein molecules which have been damaged due to the crosslinking reaction caused by the formalin fixation treatment, but also for facilitating an approach of the digestive enzyme to protein molecules in the subsequent enzymatic treatment.
- the deparaffinized tissue section is immersed in a retrieval treatment solution containing a surfactant, and a heat treatment (in a hot bath, a microwave oven or an autoclave) is performed on the immersed sample for a predetermined period of time.
- Non-Patent Document 1 Maurizio Ronci, Maria Bonanno, Alfredo Colantoni, Luisa Pieroni, Carmine Di Ilio, Luigi Giusto Spagnoli, Giorgio Federici and Andrea Urbani, “Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: Application to MALDI-TOF Imaging MS investigations”, Proteomics, vol. 8, 2008, pp. 3702-3714
- Non-Patent Document 2 M. Reid Groseclose, Pierre P. Massion, Pierre Chaurand, and Richard M. Caprioli, “High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry”, Proteomics, Vol. 8, No. 18, 2008, pp. 3715-3724
- Non-Patent Document 3 Marie-Claude Djidja, Emmanuelle Claude, Marten F. Sne, Peter Scriven, Simona Francese, Vikki Carolan and Malcolm R. Clench, “MALDI-Ion Mobility Separation-Mass Spectrometry Imaging of Glucose-Regulated Protein 78 kDa (Grp78) in Human Formalin-Fixed, Paraffin-Embedded Pancreatic Adenocarcinoma Tissue Sections”, Journal of Proteome Research, Vol. 8, No. 10, 2009, pp. 4876-4884
- Non-Patent Document 4 Johan O. R. Gustafsson, Martin K. Oehler, Shaun R. McColl and Peter Hoffmann, “Citric Acid Antigen Retrieval (CAAR) for Tryptic Peptide Imaging Directly on Archived Formalin-Fixed Paraffin-Embedded Tissue”, Journal of Proteome Research, Vol. 9, No. 9, 2010, pp. 4315-4328
- the problem to be solved by the present invention is to provide a system and method for a retrieval treatment of proteins in a deparaffinized tissue section in which the loss of biological substances from the tissue section does not occur in the process of activating the proteins in the deparaffinized tissue section, and therefore, the peaks can be detected with adequate intensities that cause no problems in a quantitative or qualitative analysis in a MALDI mass spectrometry, so that a larger amount of information is available for the image mapping.
- a system for a retrieval treatment of proteins in a deparaffinized tissue section aimed at solving the previously describe problem is a protein retrieval treatment system for retrieval of protein molecules in a measurement area on a deparaffinized tissue section prepared by removing paraffin from a formalin-fixed paraffin-embedded tissue section obtained by a formalin-fixing treatment followed by a paraffin-embedding treatment, the retrieval being performed for a mass spectrometry of the measurement area and achieved by dissociating a crosslink resulting from formalin fixation in the protein molecules contained in the measurement area, and the system including:
- a dispensing unit for dispensing a retrieval treatment solution over a dispensing area including the measurement area on the deparaffinized tissue section;
- a moist-heat treatment unit for heating, by using a saturated water vapor, the deparaffinized tissue section with the retrieval treatment solution put on the dispensing area.
- the system for a retrieval treatment of proteins in a deparaffinized tissue section is designed so as to exclude, from the retrieval treatment, the conventional process of immersing the deparaffinized tissue section in a retrieval treatment solution and washing the tissue section after the immersing.
- a retrieval treatment solution is dispensed in the dispensing unit onto the deparaffinized tissue section, the deparaffinized tissue section is subjected to the moist-heat treatment.
- the retrieval treatment solution should preferably contain a surfactant.
- Adding a surfactant to the retrieval treatment solution improves the affinity between the retrieval treatment solution and the deparaffinized tissue section, so that the crosslink resulting from the formalin fixation can be adequately dissociated when subjected to the moist-heat treatment.
- the dispensing unit may dispense the retrieval treatment solution at predetermined space intervals so as to form a plurality of droplets separated from each other within the dispensing area.
- the volume of each of the droplets and the space intervals of the droplets should preferably be set so that the dispensing area is covered with the plurality of droplets.
- the dispensing unit may be configured so that it dispenses the retrieval treatment solution a plurality of times onto the same spot within the dispensing area.
- a method for a retrieval treatment of proteins in a deparaffinized tissue section aimed at solving the previously described problem is a protein retrieval treatment method for retrieval of protein molecules in a measurement area on a deparaffinized tissue section prepared by removing paraffin from a formalin-fixed paraffin-embedded tissue section obtained by a formalin-fixing treatment followed by a paraffin-embedding treatment, the retrieval being performed for a mass spectrometry of the measurement area and achieved by dissociating a crosslink resulting from formalin fixation in protein molecules contained in the measurement area, and the method including:
- the retrieval treatment solution may be dispensed at predetermined space intervals so as to form a plurality of droplets separated from each other within the dispensing area.
- the volume of each of the droplets and the space intervals of the droplets should preferably be set so that the dispensing area is covered with the plurality of droplets.
- the retrieval treatment solution may be dispensed a plurality of times onto the same spot within the dispensing area.
- the pH of the retrieval treatment solution may be equal to or higher than 9.
- the loss of biological substances from the deparaffinized tissue section due to the immersing does not occur, since the deparaffinized tissue section is not immersed in a retrieval treatment solution as in the conventional case; instead, the retrieval treatment solution is dispensed on the deparaffinized tissue section before the moist-heat treatment is performed. Furthermore, since the washing process which has conventionally been needed after the retrieval treatment is omitted, the loss of biological substances from the deparaffinized tissue section due to the washing does not occur.
- the actual amounts of biological substances will be correctly reflected in the peak intensities, so that the peak intensities obtained by a MALDI mass spectrometry will be higher than in the conventional case.
- the increase in the peak intensities leads to an increased number of peaks whose chemical structures can be identified by a qualitative analysis as well as an improved detection limit in a quantitative analysis. As a result, a more accurate mapping image with a greater amount of information can be created.
- FIG. 1 is a flowchart showing a method of pretreating a paraffin-embedded tissue section by using a retrieval treatment system according to the present invention.
- FIG. 2 is a flowchart showing a method of pretreating a paraffin-embedded tissue section by using a conventional retrieval treatment method.
- FIG. 3 is a configuration diagram showing the main components of a retrieval treatment system according to one embodiment of the present invention.
- FIG. 4A is a model diagram illustrating a retrieval treatment according to one example of the present invention
- FIG. 4B is a model diagram illustrating a MALDI mass spectrometry according to the present example.
- FIG. 5 is a bar graph showing the number of detected peaks with respect to the dispensing amount of the retrieval treatment solution.
- FIG. 6 shows mass peak profiles obtained in the present example and in a comparative example for each of the predetermined mass ranges.
- FIG. 7 shows enlarged views of major peaks detected in the present example and in the comparative example, where the thicker and thinner lines correspond to the present example and the comparative example, respectively.
- FIG. 8 is a bar graph showing, for each mass range, the intensity ratios of the peaks detected in the present example to those of the peaks detected in the comparative example.
- FIG. 3 is a configuration diagram showing the main components of the retrieval treatment system 1 according to the present embodiment.
- the retrieval treatment system 1 is composed of a dispensing unit 10 for dispensing a retrieval treatment solution onto a deparaffinized tissue section 30 and a moist-heat treatment unit 20 for heating, in a saturated water vapor, the deparaffinized tissue section 30 with a retrieval treatment solution 31 put on it.
- the dispensing unit 10 includes: a platform 11 on which a sample plate 34 with the deparaffinized tissue section 30 put thereon is to be placed, a solution storage container (not shown) for holding a retrieval treatment solution, and a dispenser 12 for dispensing the retrieval treatment solution.
- a sample plate 34 carrying the deparaffinized tissue section 30 with the retrieval treatment solution 31 put thereon is loaded in a pressure-resistant container, and the deparaffinized tissue section 30 is heated with a saturated water vapor at a predetermined temperature for a predetermined period of time.
- any dispensing device capable of dispensing a trace amount of solution onto a specified area can be used.
- a particularly suitable example is a chemical printer CHIP-1000 (manufactured by Shimadzu Corporation), which is capable of dispensing a picoliter-size droplet.
- the moist-heat treatment unit 20 an autoclave can suitably be used.
- the dispensing unit 10 and the moist-heat treatment unit 20 may be provided separately from each other or integrally as a single unit.
- the dispensing unit 10 can not only be used for dispensing the retrieval treatment solution but also for applying a predetermined treatment solution to the deparaffinized tissue section 30 in the subsequent enzymatic treatment and the matrix deposition treatment.
- retrieval treatment method One example of the method for a retrieval treatment of proteins in a deparaffinized tissue section, which was performed by the previously described retrieval treatment system 1 , is hereinafter described (this method is hereinafter simply called the “retrieval treatment method”).
- the retrieval treatment was performed under a plurality of dispensing conditions in order to find an optimum dispensing amount of the retrieval treatment solution.
- the aforementioned chemical printer CHIP-1000 was used as the dispensing unit 10 of the retrieval treatment system 1
- the autoclave KS-243 manufactured by TOMY SEIKO CO., LTD
- the moist-heat treatment unit 20 was used as the moist-heat treatment unit 20 .
- a piece of kidney tissue of a mouse was fixed with formalin, after which the tissue was embedded in paraffin and sliced to obtain a formalin-fixed paraffin-embedded kidney tissue section (3 ⁇ m thick). Then, the tissue section was laid on an electrically conductive support and dried. The obtained formalin-fixed paraffin-embedded kidney tissue section was exposed to xylene at room temperature for 30 minutes to remove paraffin and obtain a deparaffinized kidney tissue section 30 . Subsequently, as a hydration treatment, the deparaffinized kidney tissue section 30 was sequentially exposed to 100% ethanol (twice), 90% ethanol, 80% ethanol and 70% ethanol, 10 seconds in each.
- the deparaffinized kidney tissue section 30 was put on a sample plate for slide glass and set in the chemical printer CHIP-1000.
- the retrieval treatment solution a 0.1% n-octyl- ⁇ -D-glucoside solution/10 mM Tris-HCl (pH 10.0) solution was put in the solution storage container.
- the retrieval treatment solution 31 was dispensed at intervals of 200 ⁇ m within each of a plurality of 1000- ⁇ m square dispensing areas 32 on the deparaffinized kidney tissue section 30 . That is to say, six spots were set at intervals of 200 ⁇ m on each side of one dispensing area 32 , and the retrieval treatment solution 31 was dispensed onto a total of 36 spots (6 spots ⁇ 6 spots).
- the measurement was performed under 11 conditions with different dispensing amount per spot: 500 pL, 1000 pL, 2000 pL, 2500 pL, 3000 pL, 3500 pL, 4000 pL, 4500 pL, 5000 pL, 7500 pL and 10000 pL.
- the volume of the retrieval treatment solution dispensed onto each spot was adjusted as desired by dropping an appropriate number of 100-pL droplets according to the required quantity (e.g., for a spot onto which a total of 2500 pL must be dispensed, a 100-pL droplet was dropped 25 times onto the tissue).
- the deparaffinized kidney tissue section 30 was put in a stainless box together with wet paper material and subjected to a moist-heat treatment in the autoclave at 110 degrees Celsius for 10 minutes.
- the deparaffinized kidney tissue section 30 was once more set in the chemical printer CHIP-1000.
- As an enzymatic treatment solution a 100 ⁇ g/mL trypsin/10 mM ammonium bicarbonate/5% isopropanol solution was put in the solution storage container. A total of 5000 pL of the enzymatic treatment solution was dispensed onto every spot where the retrieval treatment solution 31 had been dispensed, after which the tissue section was left in a thermostatic chamber at 37 degrees Celsius for 180 minutes to hydrolyze proteins contained in the dispensing area 32 of the deparaffinized kidney tissue section 30 .
- a 50 mg/mL 2,5-dihydroxy benzoic acid/50% acetonitrile/0.1% trifluoroacetic acid solution was put in the solution storage container and dispensed at intervals of 150 ⁇ m with a total of 7500 pL for each dispensing spot so as to deposit 2,5-dihydroxy benzoic acid on the deparaffinized kidney tissue section 30 .
- the section sample thus obtained was subjected to a MALDI mass spectrometry. The conditions of the MALDI mass spectrometry will be described later.
- the retrieval treatment solution used in the previously described retrieval treatment was adjusted at pH 9.6. Biasing the pH of the retrieval treatment solution toward the basic side in this manner improves the reaction rate of the hydrolysis of proteins by trypsin in the subsequent enzymatic treatment since trypsin has an weakly-basic optimum pH (from pH 8 to 9).
- a formalin-fixed paraffin-embedded kidney tissue section of a mouse was treated as follows based on the conventional method.
- the deparaffinized kidney tissue section 30 which had undergone the deparaffinization and hydration treatments in the same manner as in the previous example was immersed in a retrieval treatment solution having the same composition as in the previous example and subjected to a moist-heat treatment in the autoclave at 110 degrees Celsius for 10 minutes. After the moist-heat treatment, the deparaffinized kidney tissue section 30 was taken out from the retrieval treatment solution and immersed in 70% ethanol for five minutes to adequately wash the deparaffinized kidney tissue section 30 . After the washing, the enzymatic treatment and the matrix deposition treatment of the deparaffinized kidney tissue section 30 were performed under the same conditions as in the previous example. The obtained section sample was subjected to a MALDI mass spectrometry under the same measurement conditions as in the previous example.
- Matrix-assisted laser desorption/ionization time-of-flight mass spectrometer AXIMA-QIT manufactured by Shimadzu Corporation
- the MALDI mass spectrometry was performed by irradiating two shots of laser beam at each point.
- the peak intensity at each mass-to-charge ratio was acquired.
- the minimum intensity of the 100 peaks on both sides of each detection peak was regarded as the background for that peak and subtracted from the peak intensity. After that, each peak intensity was corrected by being divided by the total of all the peak intensities.
- Each peak detected in the present example was compared with the peak detected at the same mass-to-charge ratio in the comparative example, and those detection peaks were selected whose intensities were equal to or higher than two times those of the comparative example and which were statistically significant (p ⁇ 0.05).
- FIG. 5 is a graph showing the number of detected peaks with respect to the dispensing amount of the retrieval treatment solution in the present example.
- the number of detected peaks showed the tendency of increasing with the dispensing amount of the retrieval treatment solution until the amount reaches 1000 pL.
- the number of detected peaks at a dispensing amount of 1000 pL was approximately two times the value at a dispensing amount of 500 pL.
- the number of detected peaks did not significantly increase while the dispensing amount was within a range from 1000 pL to 2500 pL.
- a probable reason is that, when the dispensing amount of the retrieval treatment solution exceeds a certain level, the droplets of the retrieval treatment solution formed on the deparaffinized kidney tissue section 30 become combined with each other, causing the retrieval treatment solution to flow to the outside of the dispensing area 32 , so that the biological substances which have been transferred into the retrieval treatment solution are lost from the dispensing area 32 .
- the deparaffinized kidney tissue section 30 after the dispensing process was visually examined in the two cases where the dispensing amount of the retrieval treatment solution per spot was 2500 pL and 5000 pL, respectively. It was confirmed that, in the case of the dispensing amount of 2500 pL, the droplet at each spot retained a good shape, whereas, in the case of the dispensing amount of 5000 pL, the droplets at the neighboring spots were combined together, causing the retrieval treatment solution to flow to the outside of the dispensing area 32 .
- the dispensing amount per spot should be 2500 pL or less so that the retrieval treatment solution can be dispensed in the form of separate droplets.
- FIG. 6 shows mass peak profiles obtained in the present example in which the retrieval treatment solution was dispensed with a volume of 2500 pL each spot (i.e. by the largest possible dispensing amount within a range where the droplets of the retrieval treatment solution can retain a good shape) and those obtained in the comparative example, with each profile showing one of the three predetermined mass ranges of m/z 750-1150, m/z 1150-1650 and m/z 1650-2250.
- the profiles of the present example generally show a larger number of clear peaks than those of the comparative example. This tendency is particularly noticeable within the mass range of m/z 1650-2250.
- FIG. 7 shows enlarged views of representative peaks (detected at m/z 1274, m/z 1443, m/z 1509, m/z 1529, m/z 1745 and m/z 1961) extracted from the mass peak profiles of FIG. 6 .
- the thicker lines show the peaks obtained in the present example in which the retrieval treatment solution was dispensed with a volume of 2500 pL each spot, while the thinner lines show the peaks obtained in the comparative example.
- the intensities of the peaks detected in the present example were equal to or higher than two times the corresponding peaks detected in the comparative example.
- FIG. 8 specifically shows, for each mass range, peak-intensity ratios of 461 peaks which were extracted from the peaks detected in the MALDI mass spectrometry of the section sample obtained in the present example in which the retrieval treatment solution was dispensed with a volume of 2500 pL each spot, and each of which had a peak intensity equal to or higher than two times the peak detected at the same mass-to-charge ratio in the comparative example.
- a peak detected at a higher mass-to-charge ratio had a tendency to have a higher peak-intensity ratio.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
A protein retrieval treatment system used for activating proteins contained in a deparaffinized tissue section obtained by removing paraffin from a formalin-fixed paraffin-embedded tissue section. The protein retrieval treatment system includes: a dispensing unit for dispensing a retrieval treatment solution over a dispensing area including a measurement area on the deparaffinized tissue section; and a moist-heat treatment unit for heating, in a saturated water vapor, the deparaffinized tissue section with the dispensing area covered with the retrieval treatment solution.
Description
- The present invention relates to a system and method for a retrieval treatment of proteins contained in a formalin-fixed paraffin-embedded tissue section obtained by a formalin-fixing treatment followed by a paraffin-embedding treatment (such a tissue section is hereinafter called the “paraffin-embedded tissue section”), and more specifically, to a retrieval treatment system and method for pretreating the aforementioned tissue section in advance of a mass spectrometry.
- In recent years, the bio-imaging technique for imaging a distribution of biological substances (such as proteins or metabolites) in a section of biological tissue has been used in the fields of clinical diagnoses or drug discoveries. In particular, this technique is widely used for an investigation of a distribution of biological substances, in which a section sample prepared by an appropriate pretreatment of a paraffin-embedded tissue section is scanned by a MALDI (matrix-assisted laser desorption ionization) mass spectrometer, and the thereby measured masses of biological substances in the section sample are comprehensively analyzed to determine the distribution of the biological substances.
- A pretreating method described in
1, 2, 3 and 4 has conventionally been used to make a paraffin-embedded tissue section available as a section sample for a mass spectrometry. This conventional pretreatment method is hereinafter described by means of the flowchart shown inNon-Patent Documents FIG. 2 . - Initially, paraffin is removed from the paraffin-embedded tissue section, after which a hydration treatment is performed to obtain a deparaffinized tissue section (S1). Inside the molecules of the proteins contained in the deparaffinized tissue section thus obtained, bonding of single amino acid residues or a formation of methylene crosslink by a hydroxyl group, in particular, a strong methylene crosslink via a primary amino or phenyl radical, have occurred. To dissociate such bonds or crosslinks (both are referred to as “crosslinks” hereinafter), the tissue section is subjected to a heat treatment in a retrieval treatment solution (S2: this treatment is hereinafter called the “retrieval treatment”). Subsequently, the retrieval treatment solution which has adhered to the deparaffinized tissue section during the retrieval treatment is washed off (S3). After the washing, the deparaffinized tissue section is treated with a digestive enzyme, such as trypsin, to hydrolyze proteins contained in the tissue section into peptides (S4). Lastly, after the enzymatic treatment, a matrix solution is dropped onto the deparaffinized tissue section to deposit the matrix on it (S5). The section sample thus prepared is subjected to the MALDI mass spectrometry.
- The retrieval treatment in the previously described conventional pretreatment method is not only indispensable for restoring two-dimensional and three-dimensional structures of the protein molecules which have been damaged due to the crosslinking reaction caused by the formalin fixation treatment, but also for facilitating an approach of the digestive enzyme to protein molecules in the subsequent enzymatic treatment. In one conventional retrieval treatment, the deparaffinized tissue section is immersed in a retrieval treatment solution containing a surfactant, and a heat treatment (in a hot bath, a microwave oven or an autoclave) is performed on the immersed sample for a predetermined period of time.
- Non-Patent Document 1: Maurizio Ronci, Elena Bonanno, Alfredo Colantoni, Luisa Pieroni, Carmine Di Ilio, Luigi Giusto Spagnoli, Giorgio Federici and Andrea Urbani, “Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: Application to MALDI-TOF Imaging MS investigations”, Proteomics, vol. 8, 2008, pp. 3702-3714
- Non-Patent Document 2: M. Reid Groseclose, Pierre P. Massion, Pierre Chaurand, and Richard M. Caprioli, “High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry”, Proteomics, Vol. 8, No. 18, 2008, pp. 3715-3724
- Non-Patent Document 3: Marie-Claude Djidja, Emmanuelle Claude, Marten F. Sne, Peter Scriven, Simona Francese, Vikki Carolan and Malcolm R. Clench, “MALDI-Ion Mobility Separation-Mass Spectrometry Imaging of Glucose-Regulated Protein 78 kDa (Grp78) in Human Formalin-Fixed, Paraffin-Embedded Pancreatic Adenocarcinoma Tissue Sections”, Journal of Proteome Research, Vol. 8, No. 10, 2009, pp. 4876-4884
- Non-Patent Document 4: Johan O. R. Gustafsson, Martin K. Oehler, Shaun R. McColl and Peter Hoffmann, “Citric Acid Antigen Retrieval (CAAR) for Tryptic Peptide Imaging Directly on Archived Formalin-Fixed Paraffin-Embedded Tissue”, Journal of Proteome Research, Vol. 9, No. 9, 2010, pp. 4315-4328
- However, when the deparaffinized tissue section is immersed in the retrieval treatment solution, a portion of the biological substances in the deparaffinized tissue section flows into the retrieval treatment solution and is lost. The loss of biological substances from the tissue section also occurs in the process of washing off the retrieval treatment solution adhered to the deparaffinized tissue section after the retrieval treatment. As a result, when a section sample prepared through the conventional retrieval treatment is subjected to a MALDI mass spectrometry, the intensities of the peaks originating from the biological substances become low, making the result of a quantitative determination incorrect or preventing a qualitative analysis of a trace amount of component. Such a situation leads to the problem that, when an image mapping is performed based on the result of the MALDI mass spectrometry, it is difficult to create a mapping image with a sufficient amount of information for correctly reflecting the true concentrations of the biological substances.
- Thus, the problem to be solved by the present invention is to provide a system and method for a retrieval treatment of proteins in a deparaffinized tissue section in which the loss of biological substances from the tissue section does not occur in the process of activating the proteins in the deparaffinized tissue section, and therefore, the peaks can be detected with adequate intensities that cause no problems in a quantitative or qualitative analysis in a MALDI mass spectrometry, so that a larger amount of information is available for the image mapping.
- A system for a retrieval treatment of proteins in a deparaffinized tissue section according to the present invention aimed at solving the previously describe problem is a protein retrieval treatment system for retrieval of protein molecules in a measurement area on a deparaffinized tissue section prepared by removing paraffin from a formalin-fixed paraffin-embedded tissue section obtained by a formalin-fixing treatment followed by a paraffin-embedding treatment, the retrieval being performed for a mass spectrometry of the measurement area and achieved by dissociating a crosslink resulting from formalin fixation in the protein molecules contained in the measurement area, and the system including:
- a dispensing unit for dispensing a retrieval treatment solution over a dispensing area including the measurement area on the deparaffinized tissue section; and
- a moist-heat treatment unit for heating, by using a saturated water vapor, the deparaffinized tissue section with the retrieval treatment solution put on the dispensing area.
- The system for a retrieval treatment of proteins in a deparaffinized tissue section according to the present invention is designed so as to exclude, from the retrieval treatment, the conventional process of immersing the deparaffinized tissue section in a retrieval treatment solution and washing the tissue section after the immersing. After a retrieval treatment solution is dispensed in the dispensing unit onto the deparaffinized tissue section, the deparaffinized tissue section is subjected to the moist-heat treatment. To make this treatment as effective as the process of immersing the deparaffinized tissue section in a retrieval treatment solution, the retrieval treatment solution should preferably contain a surfactant. Adding a surfactant to the retrieval treatment solution improves the affinity between the retrieval treatment solution and the deparaffinized tissue section, so that the crosslink resulting from the formalin fixation can be adequately dissociated when subjected to the moist-heat treatment.
- In the previously described retrieval treatment system, the dispensing unit may dispense the retrieval treatment solution at predetermined space intervals so as to form a plurality of droplets separated from each other within the dispensing area.
- In this case, the volume of each of the droplets and the space intervals of the droplets should preferably be set so that the dispensing area is covered with the plurality of droplets.
- The dispensing unit may be configured so that it dispenses the retrieval treatment solution a plurality of times onto the same spot within the dispensing area.
- A method for a retrieval treatment of proteins in a deparaffinized tissue section according to the present invention aimed at solving the previously described problem is a protein retrieval treatment method for retrieval of protein molecules in a measurement area on a deparaffinized tissue section prepared by removing paraffin from a formalin-fixed paraffin-embedded tissue section obtained by a formalin-fixing treatment followed by a paraffin-embedding treatment, the retrieval being performed for a mass spectrometry of the measurement area and achieved by dissociating a crosslink resulting from formalin fixation in protein molecules contained in the measurement area, and the method including:
- a dispensing process in which a retrieval treatment solution is dispensed over a dispensing area including the measurement area on the deparaffinized tissue section; and
- a moist-heat treatment process in which the deparaffinized tissue section with the retrieval treatment solution put on the dispensing area is heated by using a saturated water vapor.
- In the dispensing process of the previously described invention, the retrieval treatment solution may be dispensed at predetermined space intervals so as to form a plurality of droplets separated from each other within the dispensing area.
- In this case, the volume of each of the droplets and the space intervals of the droplets should preferably be set so that the dispensing area is covered with the plurality of droplets.
- In the dispensing process, the retrieval treatment solution may be dispensed a plurality of times onto the same spot within the dispensing area.
- The pH of the retrieval treatment solution may be equal to or higher than 9.
- In the system and method for a retrieval treatment of proteins in a deparaffinized tissue section according to the present invention, the loss of biological substances from the deparaffinized tissue section due to the immersing does not occur, since the deparaffinized tissue section is not immersed in a retrieval treatment solution as in the conventional case; instead, the retrieval treatment solution is dispensed on the deparaffinized tissue section before the moist-heat treatment is performed. Furthermore, since the washing process which has conventionally been needed after the retrieval treatment is omitted, the loss of biological substances from the deparaffinized tissue section due to the washing does not occur. Accordingly, the actual amounts of biological substances will be correctly reflected in the peak intensities, so that the peak intensities obtained by a MALDI mass spectrometry will be higher than in the conventional case. The increase in the peak intensities leads to an increased number of peaks whose chemical structures can be identified by a qualitative analysis as well as an improved detection limit in a quantitative analysis. As a result, a more accurate mapping image with a greater amount of information can be created.
-
FIG. 1 is a flowchart showing a method of pretreating a paraffin-embedded tissue section by using a retrieval treatment system according to the present invention. -
FIG. 2 is a flowchart showing a method of pretreating a paraffin-embedded tissue section by using a conventional retrieval treatment method. -
FIG. 3 is a configuration diagram showing the main components of a retrieval treatment system according to one embodiment of the present invention. -
FIG. 4A is a model diagram illustrating a retrieval treatment according to one example of the present invention, andFIG. 4B is a model diagram illustrating a MALDI mass spectrometry according to the present example. -
FIG. 5 is a bar graph showing the number of detected peaks with respect to the dispensing amount of the retrieval treatment solution. -
FIG. 6 shows mass peak profiles obtained in the present example and in a comparative example for each of the predetermined mass ranges. -
FIG. 7 shows enlarged views of major peaks detected in the present example and in the comparative example, where the thicker and thinner lines correspond to the present example and the comparative example, respectively. -
FIG. 8 is a bar graph showing, for each mass range, the intensity ratios of the peaks detected in the present example to those of the peaks detected in the comparative example. - One embodiment of the system for a retrieval treatment of proteins in a deparaffinized tissue section according to the present invention is hereinafter described with reference to the attached drawings (the system is hereinafter simply called the “retrieval treatment system”).
FIG. 3 is a configuration diagram showing the main components of theretrieval treatment system 1 according to the present embodiment. - The
retrieval treatment system 1 is composed of a dispensingunit 10 for dispensing a retrieval treatment solution onto adeparaffinized tissue section 30 and a moist-heat treatment unit 20 for heating, in a saturated water vapor, thedeparaffinized tissue section 30 with aretrieval treatment solution 31 put on it. - The dispensing
unit 10 includes: aplatform 11 on which asample plate 34 with thedeparaffinized tissue section 30 put thereon is to be placed, a solution storage container (not shown) for holding a retrieval treatment solution, and adispenser 12 for dispensing the retrieval treatment solution. - In the moist-
heat treatment unit 20, asample plate 34 carrying thedeparaffinized tissue section 30 with theretrieval treatment solution 31 put thereon is loaded in a pressure-resistant container, and thedeparaffinized tissue section 30 is heated with a saturated water vapor at a predetermined temperature for a predetermined period of time. - As the dispensing
unit 10, any dispensing device capable of dispensing a trace amount of solution onto a specified area can be used. A particularly suitable example is a chemical printer CHIP-1000 (manufactured by Shimadzu Corporation), which is capable of dispensing a picoliter-size droplet. As the moist-heat treatment unit 20, an autoclave can suitably be used. - The dispensing
unit 10 and the moist-heat treatment unit 20 may be provided separately from each other or integrally as a single unit. The dispensingunit 10 can not only be used for dispensing the retrieval treatment solution but also for applying a predetermined treatment solution to thedeparaffinized tissue section 30 in the subsequent enzymatic treatment and the matrix deposition treatment. - One example of the method for a retrieval treatment of proteins in a deparaffinized tissue section, which was performed by the previously described
retrieval treatment system 1, is hereinafter described (this method is hereinafter simply called the “retrieval treatment method”). In the present example, the retrieval treatment was performed under a plurality of dispensing conditions in order to find an optimum dispensing amount of the retrieval treatment solution. - In the present example, the aforementioned chemical printer CHIP-1000 was used as the dispensing
unit 10 of theretrieval treatment system 1, and the autoclave KS-243 (manufactured by TOMY SEIKO CO., LTD) was used as the moist-heat treatment unit 20. - A piece of kidney tissue of a mouse was fixed with formalin, after which the tissue was embedded in paraffin and sliced to obtain a formalin-fixed paraffin-embedded kidney tissue section (3 μm thick). Then, the tissue section was laid on an electrically conductive support and dried. The obtained formalin-fixed paraffin-embedded kidney tissue section was exposed to xylene at room temperature for 30 minutes to remove paraffin and obtain a deparaffinized
kidney tissue section 30. Subsequently, as a hydration treatment, the deparaffinizedkidney tissue section 30 was sequentially exposed to 100% ethanol (twice), 90% ethanol, 80% ethanol and 70% ethanol, 10 seconds in each. - After the hydration treatment, the deparaffinized
kidney tissue section 30 was put on a sample plate for slide glass and set in the chemical printer CHIP-1000. As the retrieval treatment solution, a 0.1% n-octyl-β-D-glucoside solution/10 mM Tris-HCl (pH 10.0) solution was put in the solution storage container. Furthermore, as shown inFIG. 4A , theretrieval treatment solution 31 was dispensed at intervals of 200 μm within each of a plurality of 1000-μmsquare dispensing areas 32 on the deparaffinizedkidney tissue section 30. That is to say, six spots were set at intervals of 200 μm on each side of one dispensingarea 32, and theretrieval treatment solution 31 was dispensed onto a total of 36 spots (6 spots×6 spots). - To find an optimum dispensing amount, the measurement was performed under 11 conditions with different dispensing amount per spot: 500 pL, 1000 pL, 2000 pL, 2500 pL, 3000 pL, 3500 pL, 4000 pL, 4500 pL, 5000 pL, 7500 pL and 10000 pL. The volume of the retrieval treatment solution dispensed onto each spot was adjusted as desired by dropping an appropriate number of 100-pL droplets according to the required quantity (e.g., for a spot onto which a total of 2500 pL must be dispensed, a 100-pL droplet was dropped 25 times onto the tissue).
- After the dispensing process, the deparaffinized
kidney tissue section 30 was put in a stainless box together with wet paper material and subjected to a moist-heat treatment in the autoclave at 110 degrees Celsius for 10 minutes. - After the moist-heat treatment, the deparaffinized
kidney tissue section 30 was once more set in the chemical printer CHIP-1000. As an enzymatic treatment solution, a 100 μg/mL trypsin/10 mM ammonium bicarbonate/5% isopropanol solution was put in the solution storage container. A total of 5000 pL of the enzymatic treatment solution was dispensed onto every spot where theretrieval treatment solution 31 had been dispensed, after which the tissue section was left in a thermostatic chamber at 37 degrees Celsius for 180 minutes to hydrolyze proteins contained in the dispensingarea 32 of the deparaffinizedkidney tissue section 30. Then, as a matrix solution, a 50 mg/mL 2,5-dihydroxy benzoic acid/50% acetonitrile/0.1% trifluoroacetic acid solution was put in the solution storage container and dispensed at intervals of 150 μm with a total of 7500 pL for each dispensing spot so as todeposit 2,5-dihydroxy benzoic acid on the deparaffinizedkidney tissue section 30. The section sample thus obtained was subjected to a MALDI mass spectrometry. The conditions of the MALDI mass spectrometry will be described later. - The retrieval treatment solution used in the previously described retrieval treatment was adjusted at pH 9.6. Biasing the pH of the retrieval treatment solution toward the basic side in this manner improves the reaction rate of the hydrolysis of proteins by trypsin in the subsequent enzymatic treatment since trypsin has an weakly-basic optimum pH (from pH 8 to 9).
- As a comparative example, a formalin-fixed paraffin-embedded kidney tissue section of a mouse was treated as follows based on the conventional method.
- The deparaffinized
kidney tissue section 30 which had undergone the deparaffinization and hydration treatments in the same manner as in the previous example was immersed in a retrieval treatment solution having the same composition as in the previous example and subjected to a moist-heat treatment in the autoclave at 110 degrees Celsius for 10 minutes. After the moist-heat treatment, the deparaffinizedkidney tissue section 30 was taken out from the retrieval treatment solution and immersed in 70% ethanol for five minutes to adequately wash the deparaffinizedkidney tissue section 30. After the washing, the enzymatic treatment and the matrix deposition treatment of the deparaffinizedkidney tissue section 30 were performed under the same conditions as in the previous example. The obtained section sample was subjected to a MALDI mass spectrometry under the same measurement conditions as in the previous example. - For each of the section samples in the present example and the comparative example, a MALDI mass spectrometry was performed under the following conditions:
- Device: Matrix-assisted laser desorption/ionization time-of-flight mass spectrometer AXIMA-QIT (manufactured by Shimadzu Corporation)
- Laser: 5 Hz, 2 shots/point
- Space intervals of irradiation: 50 μm
- Ion polarity: positive
- Mode of measurement mass area: MID MASS
- Mass range to be measured: m/z 700-2500
- Measurement area: 500 μm×500 μm
- Measurement points: 11×11=121 points
- As schematically shown in
FIG. 4B , for each of the 121 points arranged at intervals of 50 μm within each of the 500-μmsquare measurement areas 33 included in the dispensingarea 32, the MALDI mass spectrometry was performed by irradiating two shots of laser beam at each point. - Within the aforementioned mass range to be measured, the peak intensity at each mass-to-charge ratio was acquired. The minimum intensity of the 100 peaks on both sides of each detection peak was regarded as the background for that peak and subtracted from the peak intensity. After that, each peak intensity was corrected by being divided by the total of all the peak intensities. Each peak detected in the present example was compared with the peak detected at the same mass-to-charge ratio in the comparative example, and those detection peaks were selected whose intensities were equal to or higher than two times those of the comparative example and which were statistically significant (p<0.05).
- The results of the MALDI mass spectrometry are hereinafter described.
-
FIG. 5 is a graph showing the number of detected peaks with respect to the dispensing amount of the retrieval treatment solution in the present example. The number of detected peaks showed the tendency of increasing with the dispensing amount of the retrieval treatment solution until the amount reaches 1000 pL. The number of detected peaks at a dispensing amount of 1000 pL was approximately two times the value at a dispensing amount of 500 pL. The number of detected peaks did not significantly increase while the dispensing amount was within a range from 1000 pL to 2500 pL. These results demonstrate that 500 pL is not a sufficient volume of the retrieval treatment solution for activating proteins in the dispensingarea 32, while the proteins in the dispensingarea 32 can be adequately activated when the dispensing amount is 1000 pL or more. - On the other hand, the number of detected peaks dramatically decreased after the dispensing amount of the retrieval treatment solution exceeded 3000 pL. A probable reason is that, when the dispensing amount of the retrieval treatment solution exceeds a certain level, the droplets of the retrieval treatment solution formed on the deparaffinized
kidney tissue section 30 become combined with each other, causing the retrieval treatment solution to flow to the outside of the dispensingarea 32, so that the biological substances which have been transferred into the retrieval treatment solution are lost from the dispensingarea 32. - To support this reasoning, the deparaffinized
kidney tissue section 30 after the dispensing process was visually examined in the two cases where the dispensing amount of the retrieval treatment solution per spot was 2500 pL and 5000 pL, respectively. It was confirmed that, in the case of the dispensing amount of 2500 pL, the droplet at each spot retained a good shape, whereas, in the case of the dispensing amount of 5000 pL, the droplets at the neighboring spots were combined together, causing the retrieval treatment solution to flow to the outside of the dispensingarea 32. - From these results, it can be said that the dispensing amount per spot should be 2500 pL or less so that the retrieval treatment solution can be dispensed in the form of separate droplets.
-
FIG. 6 shows mass peak profiles obtained in the present example in which the retrieval treatment solution was dispensed with a volume of 2500 pL each spot (i.e. by the largest possible dispensing amount within a range where the droplets of the retrieval treatment solution can retain a good shape) and those obtained in the comparative example, with each profile showing one of the three predetermined mass ranges of m/z 750-1150, m/z 1150-1650 and m/z 1650-2250. The profiles of the present example generally show a larger number of clear peaks than those of the comparative example. This tendency is particularly noticeable within the mass range of m/z 1650-2250. -
FIG. 7 shows enlarged views of representative peaks (detected at m/z 1274, m/z 1443, m/z 1509, m/z 1529, m/z 1745 and m/z 1961) extracted from the mass peak profiles ofFIG. 6 . The thicker lines show the peaks obtained in the present example in which the retrieval treatment solution was dispensed with a volume of 2500 pL each spot, while the thinner lines show the peaks obtained in the comparative example. At any of those m/z values, the intensities of the peaks detected in the present example were equal to or higher than two times the corresponding peaks detected in the comparative example. -
FIG. 8 specifically shows, for each mass range, peak-intensity ratios of 461 peaks which were extracted from the peaks detected in the MALDI mass spectrometry of the section sample obtained in the present example in which the retrieval treatment solution was dispensed with a volume of 2500 pL each spot, and each of which had a peak intensity equal to or higher than two times the peak detected at the same mass-to-charge ratio in the comparative example. A peak detected at a higher mass-to-charge ratio had a tendency to have a higher peak-intensity ratio. In the aforementioned 461 peaks, 182 peaks (39.5%) had their intensities improved to 2-3 times the levels in the comparative example, 149 peaks (32.3%) had their intensities improved to 3-5 times, 104 peaks (22.6%) had their intensities improved to 5-10 times, and 26 peaks (5.6%) had their intensities improved to higher than 10 times. - As described thus far, by using the retrieval treatment system and retrieval treatment method according to the present invention, a larger number of peaks will be detected with a higher detection sensitivity in a MALDI mass spectrometry than in the case where the retrieval treatment is performed by the conventional method. This is probably because the conventional process of immersing the sample in the retrieval treatment solution and subsequently washing the sample is omitted, and therefore, the loss of biological substances from the deparaffinized tissue section is avoided. Furthermore, it is expected that the molecules of the biological substances and those of the components of the retrieval treatment solution frequently collide with each other inside the micro-sized droplets of the retrieval treatment solution during the moist-heat treatment. This phenomenon probably promotes the retrieval and thereby improves the detection sensitivity.
- It should be noted that the specific forms of the present invention described thus far do not limit the present invention. For example, although the dispensing areas and the measurement areas shown in the drawings were shaped rectangular, they may have any other shapes, such as a circular shape. Various other changes can be made without departing from the spirit of the present invention.
-
- 1 . . . Retrieval Treatment System
- 10 . . . Dispensing Unit
- 11 . . . Platform
- 12 . . . Dispenser
- 20 . . . Moist-Heat Treatment Unit
- 30 . . . Deparaffinized Tissue Section
- 31 . . . Retrieval Treatment Solution
- 32 . . . Dispensing Area
- 33 . . . Measurement Area
- 34 . . . Sample Plate
Claims (9)
1. A protein retrieval treatment system for retrieval of protein molecules in a measurement area on a deparaffinized tissue section prepared by removing paraffin from a formalin-fixed paraffin-embedded tissue section obtained by a formalin-fixing treatment followed by a paraffin-embedding treatment, the retrieval being performed for a mass spectrometry of the measurement area and achieved by dissociating a crosslink resulting from formalin fixation in the protein molecules contained in the measurement area, and the system comprising:
a dispensing unit for dispensing a retrieval treatment solution over a dispensing area including the measurement area on the deparaffinized tissue section; and
a moist-heat treatment unit for heating, by using a saturated water vapor, the deparaffinized tissue section with the retrieval treatment solution put on the dispensing area.
2. The protein retrieval treatment system according to claim 1 , wherein the dispensing unit dispenses the retrieval treatment solution at predetermined space intervals so as to form a plurality of droplets separated from each other within the dispensing area.
3. The protein retrieval treatment system according to claim 2 , wherein a volume of each of the droplets and the space intervals of the droplets are set so that the dispensing area is covered with the plurality of droplets.
4. The protein retrieval treatment system according to claim 1 , wherein the dispensing unit dispenses the retrieval treatment solution a plurality of times onto a same spot within the dispensing area.
5. A protein retrieval treatment method for retrieval of protein molecules in a measurement area on a deparaffinized tissue section prepared by removing paraffin from a formalin-fixed paraffin-embedded tissue section obtained by a formalin-fixing treatment followed by a paraffin-embedding treatment, the retrieval being performed for a mass spectrometry of the measurement area and achieved by dissociating a crosslink resulting from formalin fixation in protein molecules contained in the measurement area, and the method comprising:
a dispensing process in which a retrieval treatment solution is dispensed over a dispensing area including the measurement area on the deparaffinized tissue section; and
a moist-heat treatment process in which the deparaffinized tissue section with the retrieval treatment solution put on the dispensing area is heated by using a saturated water vapor.
6. The protein retrieval treatment method according to claim 5 , wherein the retrieval treatment solution is dispensed at predetermined space intervals so as to form a plurality of droplets separated from each other within the dispensing area.
7. The protein retrieval treatment method according to claim 6 , wherein a volume of each of the droplets and the space intervals of the droplets are set so that the dispensing area is covered with the plurality of droplets.
8. The protein retrieval treatment method according to claim 5 , wherein the retrieval treatment solution is dispensed a plurality of times onto a same spot within the dispensing area.
9. The protein retrieval treatment method according to claim 5 , wherein a pH of the retrieval treatment solution is equal to or higher than 9.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011-117334 | 2011-05-25 | ||
| JP2011117334 | 2011-05-25 | ||
| PCT/JP2012/061090 WO2012160934A1 (en) | 2011-05-25 | 2012-04-25 | Activation treatment system and activation treatment method for protein in formalin-fixed paraffin-embedded tissue section |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2012/061090 A-371-Of-International WO2012160934A1 (en) | 2011-05-25 | 2012-04-25 | Activation treatment system and activation treatment method for protein in formalin-fixed paraffin-embedded tissue section |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/978,115 Division US10018539B2 (en) | 2011-05-25 | 2015-12-22 | System and method for retrieval treatment of proteins in formalin-fixed paraffin-embedded tissue section |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20140220624A1 true US20140220624A1 (en) | 2014-08-07 |
Family
ID=47217017
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/119,639 Abandoned US20140220624A1 (en) | 2011-05-25 | 2012-04-25 | System and method for retrieval treatment of proteins in formalin-fixed paraffin-embedded tissue section |
| US14/978,115 Active US10018539B2 (en) | 2011-05-25 | 2015-12-22 | System and method for retrieval treatment of proteins in formalin-fixed paraffin-embedded tissue section |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/978,115 Active US10018539B2 (en) | 2011-05-25 | 2015-12-22 | System and method for retrieval treatment of proteins in formalin-fixed paraffin-embedded tissue section |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20140220624A1 (en) |
| JP (1) | JP5775156B2 (en) |
| WO (1) | WO2012160934A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106030309B (en) * | 2013-12-12 | 2019-11-26 | 休斯敦大学系统 | Universal antigen retrieval compounds and methods of use thereof |
| CN110864939A (en) * | 2018-08-27 | 2020-03-06 | 深圳大学 | Protein extraction method and application |
| JP7215467B2 (en) * | 2019-08-19 | 2023-01-31 | 株式会社島津製作所 | Method for separating, detecting and/or analyzing antibodies from formalin-fixed, paraffin-embedded tissue samples |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4457742B2 (en) * | 2003-04-30 | 2010-04-28 | 株式会社島津製作所 | Method for dispensing reagent to biological specimen and method for analyzing biological specimen |
| US20040219588A1 (en) | 2003-04-30 | 2004-11-04 | Masaru Furuta | Method for dispensing reagents onto biological samples and method for analyzing biological samples |
| US8012693B2 (en) | 2003-12-16 | 2011-09-06 | 3M Innovative Properties Company | Analysis of chemically crosslinked cellular samples |
| CA2590573A1 (en) * | 2004-12-17 | 2006-06-22 | Ventana Medical Systems, Inc. | High temperature tissue conditioning with low volatility solutions and applications |
| WO2006127860A2 (en) * | 2005-05-25 | 2006-11-30 | Expression Pathology, Inc. | Multiplex method for increased proteomic coverage from histopathologically processed biological samples using liquid tissue preparations |
| AU2007300996B2 (en) * | 2006-09-28 | 2013-10-31 | Shimadzu Corporation | Method for deparaffinization of paraffin-embedded specimen and method for analysis of paraffin-embedded specimen |
-
2012
- 2012-04-25 WO PCT/JP2012/061090 patent/WO2012160934A1/en not_active Ceased
- 2012-04-25 JP JP2013516264A patent/JP5775156B2/en active Active
- 2012-04-25 US US14/119,639 patent/US20140220624A1/en not_active Abandoned
-
2015
- 2015-12-22 US US14/978,115 patent/US10018539B2/en active Active
Non-Patent Citations (2)
| Title |
|---|
| Bankfalvi et al. J of Pathology, 1994, 174:223-228. * |
| Shiurba et al. Brain Research Protocols, 1998, 2:109-119. * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2012160934A1 (en) | 2014-07-31 |
| WO2012160934A1 (en) | 2012-11-29 |
| JP5775156B2 (en) | 2015-09-09 |
| US10018539B2 (en) | 2018-07-10 |
| US20160153872A1 (en) | 2016-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schwartz et al. | Direct tissue analysis using matrix‐assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation | |
| Krüger et al. | Analyte incorporation and ionization in matrix-assisted laser desorption/ionization visualized by pH indicator molecular probes | |
| Hillenkamp et al. | The MALDI process and method | |
| Chalmers et al. | Protein kinase A phosphorylation characterized by tandem Fourier transform ion cyclotron resonance mass spectrometry | |
| US20050196786A1 (en) | Multiplex spatial profiling of gene expression | |
| Gessel et al. | Decellularization of intact tissue enables MALDI imaging mass spectrometry analysis of the extracellular matrix | |
| JP2006504971A (en) | Quantitative analysis of protein isoforms by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry | |
| JP2012529058A (en) | Mass spectrometry using laser spray ionization | |
| Inutan et al. | Laserspray ionization, a new method for protein analysis directly from tissue at atmospheric pressure with ultrahigh mass resolution and electron transfer dissociation | |
| CN102388304A (en) | Method for Forming Quality Images | |
| US10018539B2 (en) | System and method for retrieval treatment of proteins in formalin-fixed paraffin-embedded tissue section | |
| US20140357526A1 (en) | Hydrogel-mediated tissue analysis | |
| Lu et al. | Soft picosecond infrared laser extraction of highly charged proteins and peptides from bulk liquid water for mass spectrometry | |
| Zubair et al. | Trypsin and MALDI matrix pre‐coated targets simplify sample preparation for mapping proteomic distributions within biological tissues by imaging mass spectrometry | |
| Flora et al. | Determination of the relative energies of activation for the dissociation of aromatic versus aliphatic phosphopeptides by ESI-FTICR-MS and IRMPD | |
| Witt et al. | Fourier transform ion cyclotron resonance mass spectrometry with NanoLC/microelectrospray ionization and matrix-assisted laser desorption/ionization: Analytical performance in peptide mass fingerprint analysis | |
| Dave et al. | Preparation and analysis of proteins and peptides using MALDI TOF/TOF mass spectrometry | |
| O'Rourke et al. | A non‐instrument‐based method for the analysis of formalin‐fixed paraffin‐embedded human spinal cord via matrix‐assisted laser desorption/ionisation imaging mass spectrometry | |
| WO2005067648A2 (en) | Multiplex spatial profiling of gene expression | |
| WO2014096847A1 (en) | Method for ion production | |
| US11614450B2 (en) | Mass spectrometry histochemistry of peptides from formaldehyde-fixed, paraffin-embedded tissue | |
| US20050112706A1 (en) | Diagnostic and prognostic methods for prostate cancers | |
| JP5751824B2 (en) | Information acquisition method | |
| TWI693402B (en) | Oligopeptide, kit and method for detecting acrylamide | |
| US10996227B2 (en) | Pre-coated surfaces for imaging biomolecules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: SHIZUOKA PREFECTURE, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:AOKI, YUTAKA;UMINO, YUKARI;SATO, TAKA-AKI;AND OTHERS;SIGNING DATES FROM 20131125 TO 20140213;REEL/FRAME:032357/0142 Owner name: SHIMADZU CORPORATION, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:AOKI, YUTAKA;UMINO, YUKARI;SATO, TAKA-AKI;AND OTHERS;SIGNING DATES FROM 20131125 TO 20140213;REEL/FRAME:032357/0142 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |